2023
DOI: 10.1158/1078-0432.22470948
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Supplementary Data from An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors

Abstract: <p>Supplementary Figure 5b</p>

Help me understand this report
View published versions

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles